Anvisa OKs Registration of Developing Products

Brazil’s Anvisa last month approved a resolution allowing drug- and devicemakers to register products that are in development, as well as technology transfers performed in a public/private or public/public partnership. The developing products must be OK’d by Brazil’s Health Ministry and the registration does not authorize the manufacturer to market the product, according to Anvisa Director-President Dirceu Barbano.
International Medical Device Regulatory Monitor